Effects of hydroxychloroquine and its metabolites in patients with connective tissue diseases

Hydroxychloroquine has attracted attention in the treatment of COVID-19. Many conflicting findings have been reported regarding the efficacy and safety of this drug, which has been used safely in the rheumatological diseases for years. However, these studies lacked measurement methods that allow acc...

Descripción completa

Detalles Bibliográficos
Autores principales: Eryavuz Onmaz, Duygu, Tezcan, Dilek, Abusoglu, Sedat, Yilmaz, Sema, Yerlikaya, Fatma Humeyra, Onmaz, Mustafa, Abusoglu, Gulsum, Unlu, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572531/
https://www.ncbi.nlm.nih.gov/pubmed/34743268
http://dx.doi.org/10.1007/s10787-021-00887-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572531/
https://www.ncbi.nlm.nih.gov/pubmed/34743268
http://dx.doi.org/10.1007/s10787-021-00887-8

Ejemplares similares